奥美拉唑+阿莫西林+呋喃唑酮根治幽门螺杆菌

Omeprazole Amoxicillin Furazolidone for Radical Treatment of Helicobacter Pylori Infection

目的探讨奥美拉唑、阿莫西林和呋喃唑酮三联疗法在小儿幽门螺旋杆菌 (hlicobacterpylori,HP)治疗中的疗效及安全性。 方法 6 5例经胃镜检查证实为消化性溃疡或慢性胃炎患儿 ,给予奥美拉唑 +阿莫西林 +呋喃唑酮治疗 14d ,1月后复查胃镜 ,并检测HP。 结果HP根治率 87.7% ,胃炎好转率 97.4% ,溃疡愈合率 94.4% ,溃疡有效率 10 0 % ,副反应发生率 4.6 %。 结论该三联疗法不失为根治率高。

Objective To explore the radical treatment of helicobacter pylori (HP) with omeprazole+amoxicillin+furazolidone in the children infected by helicobacter pylori (HP), and its safety and cost. Methods 65 children were confirmed to suffer from peptic ulcer or chronic gastritis by gastroscopy and were treated with omeprazole+amoxicillin+furazolidone for 14d, and re-examined for HP by gastroscopy one month after therapy. Results The radical treatment rate of HP was 87.7%. The effective rate of gastritis was 97.4%. The healing rate of peptic ulcer was 94.9%, and the effective rate of peptic ulcer was 100%. The rate of side effects was 4.6%. The cost of anti-HP therapy was about 250.54 yuan (RMB) in children about 12 years old. Conclusion This therapy can achieve good results in the radical treatment of HP infection. It has few side effects and a low cost.